Angiodynamics Inc
ANGO
David D. Helsel
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About David D. Helsel
Angiodynamics Inc reported in an 8-K filed January 5, 2024 that David D. Helsel resigned as Senior Vice President of Global Operations and R&D, effective January 12, 2024. The proxy statement of Angiodynamics Inc reports total compensation of $785,625 for David D. Helsel in fiscal 2023, including a base salary of $371,345. Disclosed compensation is on record for 6 fiscal years.
“On December 29, 2023, David D. Helsel, Senior Vice President of Global Operations and R&D, notified the Company of his intention to leave the Company, effective January 12, 2024, in order to pursue other opportunities.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Angiodynamics Inc (ANGO)
Proxy statement
Start not stated–2024-01-12
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Angiodynamics Inc (ANGO) | SVP, Global Operations and R&D | $371,345 | $785,625 |
| 2022 | Angiodynamics Inc (ANGO) | SVP, Global Operations and R&D | $360,529 | $1,023,657 |
| 2021 | Angiodynamics Inc (ANGO) | SVP, Global Operations and R&D | $352,000 | $960,366 |
| 2020 | Angiodynamics Inc (ANGO) | SVP, Global Operations and R&D | $349,835 | $769,356 |
| 2019 | Angiodynamics Inc (ANGO) | SVP, Global Operations and R&D | $333,945 | $958,262 |
| 2018 | Angiodynamics Inc (ANGO) | SVP, Global Operations and R&D | $133,481 | $826,829 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.